1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67DDDA7DFD7267A5585257CEB005F46A4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-ipad-utilization-in-managed-markets-training-integration-and-productivity-apps?opendocument
18
19opendocument
20107.23.176.162
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Managed Care Organizations and Winning Practices

iPad Utilization in Managed Markets: Training, Integration and Productivity Apps

ID: 5310


Features:

11 Info Graphics

17 Data Graphics

75 Metrics


Pages/Slides: 35


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "iPad Utilization in Managed Markets: Training, Integration and Productivity Apps"


STUDY OVERVIEW

As technology continues to evolve, companies will look for ways to adopt processes and tools that improve marketplace penetration. To that end, the iPad has become a popular tool for managed markets teams at biopharma and medical device companies. However, deploying iPads into the field requires significant planning, resources and training to make the investment a success.

Best Practices, LLC performed this research study to identify best practices for deploying and integrating the iPad as an innovative tool for managed markets teams. The 2013 research is focused on issues of training, systems integration and application development for the iPad.


These research findings provide industry metrics and insights that can serve as a reference point for managed markets leaders as they seek to deploy and improve the usage of iPads in their groups.

KEY TOPICS

  • Benchmark Participant Demographics
  • Current State of iPad Deployment
  • Training for iPad Devices
  • iPad Integration and Systems Development
  • Productivity Applications for iPads

SAMPLE KEY METRICS
  • Level of deployment in commercial organization
  • Plans to streamline technology in the future
  • Technological set-up in which managed markets staff are currently equipped
  • Peripheral devices deployed to complement your use of an iPad in the field
  • Department responsible for implementing and training in iPAD use
  • Types of training used when iPads are distributed
  • Length of training programs for iPad usage
  • Standardization of training regardless of region or therapeutic area
  • Commercial factors that play a role in driving customized training
  • Types of training formats used to educate staff about their new devices
  • Group responsibility for streamlining and integrating iPads into their existing computer networks
  • Group ownership for creating software and applications for iPads
  • Status of CRM application installed on iPad & top CRM vendors
  • Status of CRM application integration to managed market teams
  • Integration status for a separate CLM platform and top vendors for CLM platform

SAMPLE KEY FINDING
  • Integration with Managed Markets: The rate of deployment is much lower for Managed Markets teams than for other field-based Sales teams. Only 29% of surveyed companies have actually implemented iPads/tablets for their Managed Markets teams. Among those companies that have deployed a tablet to Managed Markets team, iPads continue to be the preferred device. These iPad adopters have used the device for an average of 17 months.
  • Current Set Up & Future Streamlining Technology to One Device: Two-thirds of the benchmark class use iPads, smartphones, and laptops as part of their current technological set-up. Still, there are drawbacks to only using an iPad, including difficulty in editing spreadsheets and presentations. Such drawbacks have prevented some companies from streamlining to one device. Of those who plan to streamline to one device, however, 60% have elected to use iPads.
METHODOLOGY

The research is based on the insights of 17 respondents from 14 leading global companies. Almost half of respondents work as directors, senior directors or vice presidents. Best Practices, LLC analysts also conducted deep-dive interviews with innovative companies to provide qualitative insights and observations.

Industries Profiled:
Pharmaceutical; Biotech; Academic; Health Care; Electronics; Biopharmaceutical; Clinical Research; Laboratories; Chemical


Companies Profiled:
Janssen; Abbvie; Boehringer Ingelheim; Rimedio; Teva Pharmaceutical Industries Ltd; Abbott Nutrition; Lung LLC; Panasonic; Novo Nordisk; Biogen Idec; Sanofi; UCB Pharma; Astellas; Genentech


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.